Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review

Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review

Abstract Irinotecan-based regimens are used worldwide for the treatment of several recurrent or advanced gastrointestinal malignancies. In this paper we describe the cases of four patients treated in our institution who developed acute dysarthria while receiving intravenous infusion of irinotecan. I...

Full description

Bibliographic Details
Main Authors: Mariagrazia De Lisa, Zelmira Ballatore, Giulia Marcantognini, Chiara Pierantoni, Stefania Antognoli, Mirco Pistelli, Alessandra Pagliacci, Rossana Berardi
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-01-01
Series:Oncology and Therapy
Subjects:
Adverse events
Dysarthria
Neurological side effects
Rinotecan
Online Access:https://doi.org/10.1007/s40487-019-00106-z

Internet

https://doi.org/10.1007/s40487-019-00106-z

Similar Items